ConductScience.org, home

Paper2936747

Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.

Bartkowski R and 7 others. J Cancer Res Clin Oncol, 1986. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model. Papers, record 2936747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2936747

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.56
iCite
Revised in PubMed
2025-07-19
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bartkowski RR
2Berger MRM R
3Aguiar JLJ L
4Henne THT H
5Dörsam JJ
6Geelhaar GHG H
7Schlag PP
8Herfarth CC

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FloxuridineMajor topic
FluorouracilMajor topic
Liver NeoplasmsMajor topic
Liver Neoplasms, ExperimentalMajor topic
Animals
DNA, Neoplasm
Liver
Rats

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
142176Standardization of the alkaline elution procedure using X-ray-damaged nuclear DNA.Tumori1979https://conductscience.org/library/papers/42176PubMed
26647987Pharmacokinetics of intra-arterial chemotherapy.Recent Results Cancer Res1983https://conductscience.org/library/papers/6647987PubMed
3939235Treatment of experimental liver tumors by continuous intra-arterial chemotherapy.Eur J Cancer (1965)1976https://conductscience.org/library/papers/939235PubMed
5151583A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil.Cancer Res1978https://conductscience.org/library/papers/151583PubMed
66648014Transient repeated dearterialization combined with intra-arterial infusion of oncolytic drugs in the treatment of liver tumors.Recent Results Cancer Res1983https://conductscience.org/library/papers/6648014PubMed
713776896A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.Radiat Res1961https://conductscience.org/library/papers/13776896PubMed
86648012Chemoembolization: a new treatment for malignant tumors and metastases.Recent Results Cancer Res1983https://conductscience.org/library/papers/6648012PubMed
96713387Incorporation of 5-fluorouracil into murine bone marrow DNA in vivo.Cancer Res1984https://conductscience.org/library/papers/6713387PubMed
1094515Improved microfluorometric DNA determination in biological material using 33258 Hoechst.Anal Biochem1979https://conductscience.org/library/papers/94515PubMed
116263474Totally implanted drug delivery system for hepatic arterial chemotherapy.Cancer Treat Rep1981https://conductscience.org/library/papers/6263474PubMed
121157835Erythroid progenitors in mouse bone marrow detected by macroscopic colony formation in culture.Exp Hematol1975https://conductscience.org/library/papers/1157835PubMed
13558823DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.Cancer Res1977https://conductscience.org/library/papers/558823PubMed
146799160Cancer statistics, 1982.CA Cancer J Clin1982https://conductscience.org/library/papers/6799160PubMed
156648018Isolated liver perfusion in dogs.Recent Results Cancer Res1983https://conductscience.org/library/papers/6648018PubMed
165402533The blood supply of experimental liver metastases. I. The distribution of hepatic artery and portal vein blood to "small" and "large" tumors.Surgery1969https://conductscience.org/library/papers/5402533PubMed
176648019First experimental and clinical results of isolated liver perfusion with cytotoxics in metastases from colorectal primary.Recent Results Cancer Res1983https://conductscience.org/library/papers/6648019PubMed
184284139Vascular distribution of hepatic tumors. Experimental study.Rev Int Hepatol1965https://conductscience.org/library/papers/4284139PubMed
206458299The incorporation of 5-fluoro-2'-deoxyuridine into DNA of mammalian tumor cells.Biochem Biophys Res Commun1981https://conductscience.org/library/papers/6458299PubMed
216648016Improved quality of life with an implantable pump for liver perfusion.Recent Results Cancer Res1983https://conductscience.org/library/papers/6648016PubMed
222936747Experiments on the efficacy and toxicity of locoregional chemotherapy of liver tumors with 5-fluoro-2'-deoxyuridine (FUDR) and 5-fluorouracil (5-FU) in an animal model.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/2936747PubMed

Download CSV of references

Cited by32

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
42306790Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis.Front Oncol2026https://conductscience.org/library/papers/42306790PubMed
42168880
Comparative safety and efficacy of hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy, with or without transarterial chemoembolization, in unresectable hepatocellular carcinoma: a multicenter retrospective cohort study.
BMC Gastroenterol2026https://conductscience.org/library/papers/42168880PubMed
41983220Phase II trial of hepatic arterial infusion chemotherapy plus bevacizumab and toripalimab for advanced biliary tract cancers: efficacy, safety, and exploratory analysis.Hepatobiliary Surg Nutr2026https://conductscience.org/library/papers/41983220PubMed
41383565Case Report: Successful Surgical Resection of PVTT Vp4 Hepatocellular Carcinoma Following Hepatic Arterial Infusion Chemotherapy Combined with Cadonilimab Plus Donafenib.Pharmgenomics Pers Med2025https://conductscience.org/library/papers/41383565PubMed
40302359
A Contrast-Enhanced Ultrasound Cine-Based Deep Learning Model for Predicting the Response of Advanced Hepatocellular Carcinoma to Hepatic Arterial Infusion Chemotherapy Combined With Systemic Therapies.
Cancer Sci2025https://conductscience.org/library/papers/40302359PubMed
40287734Predictive factors and prognostic models for Hepatic arterial infusion chemotherapy in Hepatocellular carcinoma: a comprehensive review.World J Surg Oncol2025https://conductscience.org/library/papers/40287734PubMed
39234395
Efficacy and safety of hepatic arterial infusion chemotherapy combined with fruquintinib and tislelizumab for patients with microsatellite stable colorectal cancer liver metastasis following failure of multiple-line therapy.
Front Oncol2024https://conductscience.org/library/papers/39234395PubMed
38911293
PD-1 Inhibitors Combined with Tyrosine Kinase Inhibitors with or without Hepatic Artery Infusion Chemotherapy for the First-Line Treatment of HBV-Related Advanced Hepatocellular Carcinoma: A Retrospective Study.
J Hepatocell Carcinoma2024https://conductscience.org/library/papers/38911293PubMed
38686567Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors: A promising treatment approach for high-burden hepatocellular carcinoma.Cancer Med2024https://conductscience.org/library/papers/38686567PubMed
38678485
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study.
Abdom Radiol (NY)2024https://conductscience.org/library/papers/38678485PubMed
38425407Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy.World J Gastrointest Oncol2024https://conductscience.org/library/papers/38425407PubMed
38393621
Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.
J Imaging Inform Med2024https://conductscience.org/library/papers/38393621PubMed
38384459Clinical and biomarker analyses of hepatic arterial infusion chemotherapy plus lenvatinib and PD-1 inhibitor for patients with advanced intrahepatic cholangiocarcinoma.Front Immunol2024https://conductscience.org/library/papers/38384459PubMed
38282664Techniques and status of hepatic arterial infusion chemotherapy for primary hepatobiliary cancers.Ther Adv Med Oncol2024https://conductscience.org/library/papers/38282664PubMed
37864725Arterial chemotherapy for hepatocellular carcinoma in China: consensus recommendations.Hepatol Int2024https://conductscience.org/library/papers/37864725PubMed
36132426Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study.J Hepatocell Carcinoma2022https://conductscience.org/library/papers/36132426PubMed
35920966Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study.J Gastrointest Surg2022https://conductscience.org/library/papers/35920966PubMed
35582475Hepatic arterial infusion of oxaliplatin plus raltitrexed in unresectable hepatocellular carcinoma with or without portal vein tumour thrombosis.Gastroenterol Rep (Oxf)2022https://conductscience.org/library/papers/35582475PubMed
35070063Neoadjuvant treatment strategies for hepatocellular carcinoma.World J Gastrointest Surg2021https://conductscience.org/library/papers/35070063PubMed
33083282Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma.Liver Cancer2020https://conductscience.org/library/papers/33083282PubMed

See all 32 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2936747

GET https://conductscience.org/api/papers/v1/2936747/cited_by?page=2